The antiviral drugs market, driven by over 500 marketed/clinical-stage drugs in the pipeline and over USD 5.5 billion in funding by investors, is expected to grow in the coming years. The Roots Analysis report features an extensive study of the current market landscape and future potential of the antiviral drugs market. It also includes an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Get a detailed insights report now!
